Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial

BACKGROUND: Although the number of antihyperglycemic agents has expanded significantly, sulfonylureas (in particular gliclazide) remain an important option because of a variety of patient and health system factors. The large, real world, observational, and international EASYDia trial evaluated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiter, Lawrence A., Shestakova, Marina V., Satman, Ilhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894204/
https://www.ncbi.nlm.nih.gov/pubmed/29651307
http://dx.doi.org/10.1186/s13098-018-0331-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894204/
https://www.ncbi.nlm.nih.gov/pubmed/29651307
http://dx.doi.org/10.1186/s13098-018-0331-8

Ejemplares similares